Company news

Belite Bio, Inc. news in 2026

Belite Bio, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Belite Bio Announces Uplisting to the Nasdaq Global Select Market

October 19, 2026

Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1

October 14, 2026

Decks in 2026